MOTS-c
A mitochondrially derived peptide studied in laboratory and animal research; not FDA-approved.
What it is
MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA — part of a newly appreciated class of mitochondrial-derived peptides involved in metabolic signaling. As science, it is genuinely exciting; as a product, it is premature.
The evidence is cell and animal work on exercise capacity and insulin sensitivity, plus the first small human safety studies. No approved product exists, and anything sold as MOTS-c today is a research chemical without verified contents.
What researchers have actually studied it for
Metabolic regulation, insulin sensitivity and exercise physiology — in cell and animal studies, with human research only beginning.
How it works
Encoded inside the mitochondrial genome's 12S rRNA region — part of why its 2015 discovery was startling — MOTS-c translocates to the cell nucleus under metabolic stress and activates AMPK-linked programs, acting like an exercise-mimetic signal between mitochondria and the genome.
Where it came from
Identified in 2015 by researchers at USC exploring 'mitochondrial-derived peptides,' a class that rewrote assumptions about what the tiny mitochondrial genome encodes. Rodent papers on exercise capacity and insulin sensitivity made it famous; first-in-human dosing studies only began years later, and the science is still young.
What the research record actually contains
- Rodent studies: improved insulin sensitivity, exercise capacity and diet-induced-obesity resistance.
- Human observational work linking MOTS-c levels to metabolic states.
- Early-phase human safety studies of analogs; no outcome trials.
What's known about risks
Too early to characterize — the honest and complete statement. Early human safety work exists for related analogs; the gray-market vial has none of it behind it.
Where it stands legally
No approval anywhere; research-chemical channel only.
Worth asking a licensed provider
- 1.If metabolic health is the goal, what does my current exercise, diet and lab picture say first?
- 2.What proven interventions produce the effects MOTS-c shows in mice?
- 3.Is there legitimate trial participation in mitochondrial-peptide research?
